🎉 The #CandyDrop Futures Challenge is live — join now to share a 6 BTC prize pool!
📢 Post your futures trading experience on Gate Square with the event hashtag — $25 × 20 rewards are waiting!
🎁 $500 in futures trial vouchers up for grabs — 20 standout posts will win!
📅 Event Period: August 1, 2025, 15:00 – August 15, 2025, 19:00 (UTC+8)
👉 Event Link: https://www.gate.com/candy-drop/detail/BTC-98
Dare to trade. Dare to win.
Harvard research findings: The weight loss drug Ozempic is associated with rare vision loss
On July 3rd, Jin10.com reported that the analysis of doctors from Massachusetts Eye and Ear, a hospital affiliated with Harvard University, showed that Novo Nordisk's popular weight-loss drugs Ozempic and Wegovy appear to be associated with an increased risk of rare vision loss. Research on medical records showed that compared to those who used other brand-name weight-loss drugs, patients who used Novo Nordisk's weight-loss drugs to lose weight were seven times more likely to develop non-arteritic anterior ischemic optic neuropathy (NAION).